GENEVA, Aug. 25 -- AC IMMUNE SA (EPFL Innovation ParkBuilding B1015 Lausanne) filed a patent application (PCT/EP2025/054124) for "ALPHA SYNUCLEIN THERAPEUTIC VACCINE" on Feb 14, 2025. With publication no. WO/2025/172592, the details related to the patent application was published on Aug 21, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): STAFFLER, Gunther (c/o AC Immune SAEPFL Innovation ParkBuilding B1015 Lausanne)
Abstract:
The present invention relates to immunogenic compositions that can be employed for the prevention, alleviation or treatment of a condition associated with diseases, ...